Nephrology News
Metastatic RCC Treatment With Nivolumab Confirmed Safe, Efficacious
The safety and efficacy of nivolumab for treating metastatic renal cell carcinoma is comparable to that found in the CheckMate 025 trial.
By accepting you will be accessing a service provided by a third-party external to https://www.galencarepartners.com/